Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Emyria Ltd ( (AU:EMD) ) has issued an update.
Emyria Limited has announced a significant expansion of its national presence by exercising an option to establish its first Empax Clinic in Victoria, marking a major milestone in its East Coast expansion. The company has secured exclusive rights to roll out Empax clinics across Avive Health’s network, enhancing its ability to provide intensive mental-health services nationwide. This expansion is supported by a successful $8 million institutional placement, which will accelerate the development of new sites and expand the clinical workforce. Additionally, Emyria has commenced revenue generation at its Brisbane clinic and has received support from the Department of Veterans’ Affairs for medication-assisted therapy, establishing a dual reimbursement pathway with private insurers.
More about Emyria Ltd
Emyria Limited is a leader in delivering evidence-based intensive mental-health care. The company focuses on providing structured, insurer-supported mental health treatments and has a strategic partnership with Avive Health to expand its clinic network across Australia.
Average Trading Volume: 4,233,375
Technical Sentiment Signal: Buy
Current Market Cap: A$44.16M
See more insights into EMD stock on TipRanks’ Stock Analysis page.